<DOC>
	<DOCNO>NCT02845765</DOCNO>
	<brief_summary>The purpose study evaluate correlation fundus oculus 's vascularization patient erectile dysfunction , , patient , use drug ED .</brief_summary>
	<brief_title>Fundus Oculi Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
	<criteria>Subjects erectile dysfunction diagnosis ( organic psychogenic ) ; Subjects Erectile Dysfunction diagnosis define IIEF score â‰¤ 25 Subjects stable partner least 6 month sexually active . Subjects age 40 60 year ; Signature inform consent patient Subjects ED secondary diagnosis hormonal alteration ( i.e . hypogonadism , hypo / hyperthyroidism , hyperprolactinemia ) ; Subjects diagnosis ED posttraumatic iatrogenic , since pelvic surgery ; Subjects suffer ocular pathology involve use contact lens / glass ; Subjects smoking ; Individuals uncontrolled systemic disease ; All person confirm least one criterion inclusion .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>ED</keyword>
	<keyword>Fundus Oculi</keyword>
	<keyword>Retinal Vascularization</keyword>
	<keyword>International Index Erectile Function Questionnaire</keyword>
	<keyword>IIEF</keyword>
	<keyword>Dynamic Vessel Analyzer</keyword>
	<keyword>DVA</keyword>
	<keyword>Phosphodiesterase type 5 Inhibitor</keyword>
	<keyword>PDE5Is</keyword>
</DOC>